218 related articles for article (PubMed ID: 9222076)
1. Oral bioavailability of trovafloxacin with and without food in healthy volunteers.
Teng R; Dogolo LC; Willavize SA; Friedman HL; Vincent J
J Antimicrob Chemother; 1997 Jun; 39 Suppl B():87-92. PubMed ID: 9222076
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics and safety of trovafloxacin in healthy male volunteers following administration of single intravenous doses of the prodrug, alatrofloxacin.
Vincent J; Venitz J; Teng R; Baris BA; Willavize SA; Polzer RJ; Friedman HL
J Antimicrob Chemother; 1997 Jun; 39 Suppl B():75-80. PubMed ID: 9222074
[TBL] [Abstract][Full Text] [Related]
3. Single- and multiple-dose administration, dosing regimens, and pharmacokinetics of trovafloxacin and alatrofloxacin in humans.
Vincent J; Dogolo L; Baris BA; Willavize SA; Teng R
Eur J Clin Microbiol Infect Dis; 1998 Jun; 17(6):427-30. PubMed ID: 9758287
[TBL] [Abstract][Full Text] [Related]
4. Effect of Maalox and omeprazole on the bioavailability of trovafloxacin.
Teng R; Dogolo LC; Willavize SA; Friedman HL; Vincent J
J Antimicrob Chemother; 1997 Jun; 39 Suppl B():93-7. PubMed ID: 9222077
[TBL] [Abstract][Full Text] [Related]
5. Penetration of trovafloxacin into cerebrospinal fluid in humans following intravenous infusion of alatrofloxacin.
Cutler NR; Vincent J; Jhee SS; Teng R; Wardle T; Lucas G; Dogolo LC; Sramek JJ
Antimicrob Agents Chemother; 1997 Jun; 41(6):1298-300. PubMed ID: 9174187
[TBL] [Abstract][Full Text] [Related]
6. The bioavailability of nasogastric versus tablet-form oral trovafloxacin in healthy subjects.
Vincent J; Teng R; Pelletier SM; Willavize SA; Friedman HL
Am J Surg; 1998 Dec; 176(6A Suppl):23S-26S. PubMed ID: 9935253
[TBL] [Abstract][Full Text] [Related]
7. Oral bioavailability and pharmacokinetics of trovafloxacin in patients with AIDS.
Lacy MK; Nicolau DP; Nightingale CH; Geffken A; Teng R; Vincent J; Quintiliani R
Antimicrob Agents Chemother; 1999 Dec; 43(12):3005-7. PubMed ID: 10582898
[TBL] [Abstract][Full Text] [Related]
8. Safety and tolerability of intravenous-to-oral treatment and single-dose intravenous or oral prophylaxis with trovafloxacin.
Williams DJ; Hopkins S
Am J Surg; 1998 Dec; 176(6A Suppl):74S-79S. PubMed ID: 9935261
[TBL] [Abstract][Full Text] [Related]
9. Concentrations of trovafloxacin in colonic tissue and peritoneal fluid after intravenous infusion of the prodrug alatrofloxacin in patients undergoing colorectal surgery.
Melnik G; Schwesinger WH; Dogolo LC; Teng R; Vincent J
Am J Surg; 1998 Dec; 176(6A Suppl):14S-17S. PubMed ID: 9935251
[TBL] [Abstract][Full Text] [Related]
10. The pharmacokinetic effects of coadministration of morphine and trovafloxacin in healthy subjects.
Vincent J; Hunt T; Teng R; Robarge L; Willavize SA; Friedman HL
Am J Surg; 1998 Dec; 176(6A Suppl):32S-38S. PubMed ID: 9935255
[TBL] [Abstract][Full Text] [Related]
11. Hepatobiliary elimination of trovafloxacin and metabolites following single oral doses in healthy volunteers.
Melnik G; Schwesinger WH; Teng R; Dogolo LC; Vincent J
Eur J Clin Microbiol Infect Dis; 1998 Jun; 17(6):424-6. PubMed ID: 9758286
[TBL] [Abstract][Full Text] [Related]
12. An open, controlled, crossover study on the effects of cimetidine on the steady-state pharmacokinetics of trovafloxacin.
Purkins L; Oliver SD; Willavize SA
Eur J Clin Microbiol Infect Dis; 1998 Jun; 17(6):431-3. PubMed ID: 9758288
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of trovafloxacin (CP-99,219), a new quinolone, in rats, dogs, and monkeys.
Teng R; Girard D; Gootz TD; Foulds G; Liston TE
Antimicrob Agents Chemother; 1996 Mar; 40(3):561-6. PubMed ID: 8851571
[TBL] [Abstract][Full Text] [Related]
14. The effect of food on the bioavailability of oral gemifloxacin in healthy volunteers.
Allen A; Bygate E; Clark D; Lewis A; Pay V
Int J Antimicrob Agents; 2000 Sep; 16(1):45-50. PubMed ID: 11185412
[TBL] [Abstract][Full Text] [Related]
15. Oral bioequivalence of three ciprofloxacin formulations following single-dose administration: 500 mg tablet compared with 500 mg/10 mL or 500 mg/5 mL suspension and the effect of food on the absorption of ciprofloxacin oral suspension.
Shah A; Liu MC; Vaughan D; Heller AH
J Antimicrob Chemother; 1999 Mar; 43 Suppl A():49-54. PubMed ID: 10225572
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of a fluoronaphthyridone, trovafloxacin (CP 99,219), in infants and children following administration of a single intravenous dose of alatrofloxacin.
Bradley JS; Kearns GL; Reed MD; Capparelli EV; Vincent J
Antimicrob Agents Chemother; 2000 May; 44(5):1195-9. PubMed ID: 10770751
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics and safety of trovafloxacin (CP-99,219), a new quinolone antibiotic, following administration of single oral doses to healthy male volunteers.
Teng R; Harris SC; Nix DE; Schentag JJ; Foulds G; Liston TE
J Antimicrob Chemother; 1995 Aug; 36(2):385-94. PubMed ID: 8522468
[TBL] [Abstract][Full Text] [Related]
18. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
Chen C; Bujanover S; Kareht S; Rapoport AM
Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics and metabolism of single oral doses of trovafloxacin.
Vincent J; Teng R; Dalvie DK; Friedman HL
Am J Surg; 1998 Dec; 176(6A Suppl):8S-13S. PubMed ID: 9935250
[TBL] [Abstract][Full Text] [Related]
20. Multiple-dose pharmacokinetics and safety of trovafloxacin in healthy volunteers.
Teng R; Liston TE; Harris SC
J Antimicrob Chemother; 1996 May; 37(5):955-63. PubMed ID: 8737145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
